	Main pulmonary artery enlargement during bevacizumab therapy in KRAS-mutant metastatic colon cancer. Cancer Chemother Pharmacol Ozbay MF, Atl, Vurgun S, Hunur M, Keven A, Sahin E, Göksu SS, Karaca M. PMID: 42752894 [PubMed - indexed for MEDLINE]
	Evaluation of MET Detection Methods and Cutoffs in EGFR-Mutated Non-small Cell Lung Cancer Following Disease Progression on Osimertinib in the phase II SAVANNAH study. Clin Cancer Res Ahn MJ, de Marinis F, Cho BC, Kim TM, Cheng S, Novello S, Proto C, Kim SW, Lee JS, Metro G, Sequist LV, Yang JC, Xu W, Telaranta-Keerie A, Todd A, D'Angelo G, Hartmaier R, Bonanno L. PMID: 42752799 [PubMed - as supplied by publisher]
	Molecules of lung cancer - fusion alterations in nonsmall cell lung cancer: biology and diagnostic considerations. Breathe (Sheff) Talty M, O'Reilly D, Dunne J, Naidoo J. PMID: 42751219 [PubMed]
	Individualized approach to palliative care integration for patients with metastatic non-small cell lung cancer. Front Med (Lausanne) Mitchell C, Kailar RS, Hsu ML. PMID: 42750937 [PubMed]
	Beyond tobacco: understanding the growing burden of lung adenocarcinoma in women. Oncol Rev Virata MCA, Abello RMR, Brillante EMB, Interior JS, Relacion PR, Molen RGC, Alea EPM, Mojica JCP. PMID: 42750867 [PubMed]
	ALPHA-1 antitrypsin genotype, sex, and lung cancer: Clinical and molecular characterisation. Pulmonology García-Rodríguez E, Tubío-Pérez RA, Candal-Pereira C, Villar-Aguilar L, Priegue-Carrera A, Fernández-Villar A, Ruano-Raviña A, Torres-Durán M. PMID: 42750455 [PubMed - indexed for MEDLINE]
	Salvage R0 Resection on Post-Recurrence Survival After Pulmonary Metastasectomy for Colorectal Cancer: A Multicenter Retrospective Study. Ann Surg Oncol Hashimoto S, Tominaga T, Shiraishi T, Noda K, Yamashita M, Katayama H, Takamura Y, Mizoguchi S, Obata T, Taniguchi D, Doi R, Shimoyama K, Miyazaki T, Hisanaga M, Ishii M, Ono R, Nakatsukasa T, Kamohara R, Araki M, Sumida Y, Nakamura A, Nonaka T, Matsumoto K. PMID: 42749975 [PubMed - as supplied by publisher]
	mRNA-based therapeutics in lung Cancer: Mechanisms, applications, and translational challenges. J Genet Eng Biotechnol Wehbe I, Tlili A. PMID: 42749398 [PubMed]
	National trends, variation and short-term outcomes in surgery for non-small cell lung cancer in England, 2015-2023: a population-based cohort study using linked national cancer registration and hospital administrative data. BMJ Open Dixon LK, Cook S, Cook A, Thomas J, Boudour J, Chan F, Conibear J, West D, Navani N, Cromwell DA. PMID: 42749376 [PubMed - indexed for MEDLINE]
	Targeting EGFR-Mutant Non-Small Cell Lung Cancer in Asia: An Update on Monotherapy and Combination TherapyÂ With EGFR Inhibitors. Respirology Sunaga N, Hasegawa Y, Sato M. PMID: 42749289 [PubMed - as supplied by publisher]
	Final Biomarker and Efficacy Analyses of Lorlatinib in Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer in a Phase 2 Study. J Thorac Oncol Bauer TM, Martini JF, Besse B, Lin CC, Soo RA, Riely GJ, Wang IM, Toffalorio F, Shepard DA, Usari T, Hamilton P, Camidge DR, Kao S, Chiari R, Gadgeel S, Felip E, Shaw AT, Solomon BJ. PMID: 42749050 [PubMed - as supplied by publisher]
	Defining Early Recurrence in Resectable Non-small Cell Lung Cancer Using Post-Recurrence Survival. Lung Naeem W, Khan AA, Rabin EE, Broad S, Denson KL, Casanova T, Basu S, Alex G, Geissen N, Liptay MJ, Seder CW. PMID: 42747627 [PubMed - indexed for MEDLINE]
	Unveiling BRAF Mutations in Non-small Cell Lung Cancer: State of the Art and Future Perspectives. Lung Colombino M, Paliogiannis P, Palomba G, Pisano M, Casula M, Fois AG, Zinellu A, Palmieri G. PMID: 42747511 [PubMed - indexed for MEDLINE]
	Statins use and prognosis in lung cancer patients treated with immune checkpoint inhibitors: evidence from a meta-analysis. Front Immunol Liang D, Liu Q, Liu M, Li Y. PMID: 42746176 [PubMed - indexed for MEDLINE]
	Associations of derived inflammatory, lipid, and anthropometric indices with CT-detected pulmonary nodules: a hospital-based cross-sectional study with explainable machine learning. Front Endocrinol (Lausanne) Wang M, Zhou Y, Wu B, Liu Y, Luo X, Zhang A. PMID: 42745967 [PubMed - indexed for MEDLINE]
	Stratifying lung adenocarcinoma: a novel prognostic model based on mitochondrial outer membrane permeabilization activity. 3 Biotech Liu D, He B, Zhou X, Yang Y, Song M, Xu X. PMID: 42745950 [PubMed]
	Clinical inflammatory shifts and peripheral flow-cytometry immune modules across benign pulmonary nodules, adenocarcinoma-spectrum nodules, and overt lung cancer. Front Immunol Rao Y, Gong Q, Li J, Liu N, Miao H, Huang J, Xu S. PMID: 42745767 [PubMed - indexed for MEDLINE]
	Plain language summary of the KRYSTAL-12 study results: adagrasib for non-small cell lung cancer with KRAS(G12C) mutations. Future Oncol Barlesi F, Yao W, Duruisseaux M, Doucet L, Azkárate Martínez A, Gregorc V, Juan-Vidal O, Lu S, De Bondt C, de Marinis F, Linardou H, Kim YC, Jotte R, Felip E, Lo Russo G, Reck M, MichenzIe MF, Yang W, Meade JN, Korytowsky B, Mok TSK, KRYSTAL-12 Investigators. PMID: 42745627 [PubMed - as supplied by publisher]
	Barriers and facilitators to population-based lung cancer screening in Belgium: a qualitative stakeholder analysis in a pre-implementation context. BMC Health Serv Res Michiels L, Duchateau J, Vangilbergen A, Verlies C, Dooms C, Van Hal G, Huys I. PMID: 42745254 [PubMed - indexed for MEDLINE]
	Oral KRAS G12D inhibitor GFH375 for previously treated advanced solid tumors with KRAS(G12D) mutations: a phase 1 trial. Nat Med Ai X, Song Z, Wu L, Zhou A, Cheng D, Zong H, Wu H, Niu Z, Sun Y, Zhu L, Li Z, Deng Y, Yuan Y, Qu X, Zhao H, Du Y, Li Z, Wang Y, Shen H, Zhu H, Zheng C, Wang S, Cui Z, Tai L, Lu S. PMID: 42745055 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 163135

Page 1 of 8157



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy